Frankfurt - Delayed Quote EUR

SomnoMed Limited (RJV.F)

0.3100
-0.0120
(-3.73%)
At close: 8:51:59 AM GMT+2

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Ms. Amrita Blickstead BME, M.B.A. Co-CEO & Executive Director 294.53k -- --
Ms. Karen Borg B.A. Co-CEO & Executive Director 333.88k -- --
Mr. Mark Harding Senior Vice President of Global Marketing 238.19k -- --
Mr. Matthew Conlon Executive VP of Sales & Marketing - North America 329.89k -- --
Mr. Marco Van Kleef Vice President of Marketing & Sales - Europe 317.18k -- --
Ms. Ye-Fei Guo Chief Financial Officer -- -- --
Mr. Terence A. Flitcroft B.Com., B.Comm., C.A., SF FIN Company Secretary 15.5k -- 1959
Mr. Christopher Bedford Vice President of Global Production and Product Development 129.95k -- --

SomnoMed Limited

20 Clarke Street
Level 3
Crows Nest, NSW 2065
Australia
61 2 9467 0400 https://somnomed.com/au/
Sector: 
Healthcare
Industry: 
Medical Devices

Description

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. In addition, it provides Sunrise, a bio-signal to diagnose sleep apnea. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.

Corporate Governance

SomnoMed Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 21, 2025 at 11:41 PM UTC - July 27, 2025 at 11:41 PM UTC

SomnoMed Limited Earnings Date

Recent Events

Waiting for permission
Allow microphone access to enable voice search

Try again.